MantleBio focuses on advancing drug discovery and development through its innovative technologies. The company employs a proprietary platform that integrates advanced computational methods with experimental biology to identify and optimize therapeutic candidates. This approach allows for a more efficient and targeted drug development process, significantly reducing the time and resources typically required in traditional methods. MantleBio's technology is designed to enhance the understanding of complex biological systems, enabling the identification of novel drug targets and the design of more effective therapeutics.

In addition to its computational capabilities, MantleBio leverages cutting-edge techniques in high-throughput screening and biomarker discovery. These technologies facilitate the rapid evaluation of potential drug candidates and the identification of patient-specific biomarkers, which are crucial for personalized medicine. By combining these methodologies, MantleBio aims to streamline the drug development pipeline, ultimately leading to the delivery of innovative treatments that address unmet medical needs.

United States

MantleBio is building software to scale data driven discovery in biotech.

It has become the norm for biotech companies to generate terabytes of data per day, but the majority of them lack the tools effectively utilize it. Through data management and analysis tools MantleBio provides an infrastructure for companies to make data driven decisions.

MantleBio

Company Details